Friday, August 5, 2016

Bristol-Myers's Opdivo Fails to Meet Goal in Lung Cancer Trial

… as a single agent for lung cancer failed in a late-stage trial … previously untreated advanced non-small cell lung cancer, compared with chemotherapy, the company … .m.
Opdivo is approved in lung cancer, though not yet as a …

No comments:

Post a Comment